The Australian pharmacy industry is undergoing a significant transformation due to recent developments such as the merger between Chemist Warehouse and Sigma Healthcare, the introduction of 60-day dispensing, the upcoming negotiations for the Eighth Community Pharmacy Agreement (8CPA), the expanding scope of pharmacy practice (ESoP), and the contentious issue of selling vapes in pharmacies. Together, these changes present challenges and opportunities for stakeholders across the sector.
Chemist Warehouse-Sigma Merger: A New Pharmacy Powerhouse
The merger between Chemist Warehouse, Australia's largest pharmacy group, and Sigma Healthcare, a leading pharmaceutical wholesaler, has reshaped the competitive landscape of the pharmacy industry. This partnership brings together Chemist Warehouse’s extensive retail network with Sigma’s strong distribution capabilities.
Key Impacts of the Merger:
- Consolidation of Market Power: This merger creates a dominant entity with significant negotiating power over suppliers, potentially leading to better procurement terms and increased profitability. However, it also raises concerns about reduced competition within the sector.
- Operational Synergies: Combining Sigma’s logistical expertise with Chemist Warehouse’s retail strategies could result in cost savings and efficiency gains, enabling more competitive pricing for customers.
- Pressure on Independent Pharmacies: The merger poses challenges for smaller, independent pharmacies, which may struggle to compete with the resources and scale of the Chemist Warehouse-Sigma group. Independent operators may need to consider joining buying groups or differentiating themselves through personalised services.
For community pharmacy owners, differentiation through high-quality patient care, specialised services, or local community involvement is key to staying competitive in the new landscape.
60-Day Dispensing: A Controversial Policy Shift
The federal government’s introduction of 60-day dispensing is another transformative change. Under this policy, eligible patients can now receive two months’ worth of medication for the price of one prescription, effectively halving the number of pharmacy visits.
Benefits:
- Cost Savings for Patients: Patients benefit from reduced medication costs and greater convenience.
- Improved Healthcare Access: Fewer pharmacy visits can improve medication adherence, especially for patients with mobility issues or those in rural areas.
Challenges:
- Revenue Decline for Pharmacies: Pharmacies face significant financial losses, as dispensing fees are halved for eligible prescriptions. Small and rural pharmacies, in particular, may struggle to remain viable under this policy.
- Supply Chain Strain: Increased demand for 60-day supplies may exacerbate existing medication shortages, especially for drugs already in short supply.
Pharmacies need to explore alternative revenue streams, such as professional health services, vaccination programs, and chronic disease management, to counterbalance revenue shortfalls.
8CPA: Shaping the Future of Community Pharmacy
The Eighth Community Pharmacy Agreement (8CPA) will shape Australia’s pharmacy sector, addressing challenges like revenue loss from 60-day dispensing and supporting small and rural pharmacies. It is expected to prioritise funding for professional services, such as medication reviews, chronic disease management, and vaccinations, while expanding pharmacists’ roles in preventative care and minor ailment treatment. Pharmacies will face economic pressures, requiring diversification, staff training, and operational restructuring to adapt. By shifting focus from dispensing to service-based care, the 8CPA aims to enhance patient outcomes, improve healthcare accessibility, and solidify the role of pharmacists in Australia’s primary healthcare system.
Expanding Scope of Pharmacy Practice (ESoP)
Australia is seeing a progressive expansion in the scope of pharmacy practice, allowing pharmacists to take on a more active role in patient care. Key developments include:
- Vaccination Programs: Pharmacists have played a significant role in administering vaccines, particularly during the COVID-19 pandemic, and this is now expanding to include other vaccines.
- Prescribing Rights: Several states are trialling pharmacist prescribing for minor ailments, contraceptives, and common chronic conditions.
- Point-of-Care Testing: Pharmacies are increasingly offering health checks such as blood pressure monitoring, cholesterol testing, and diabetes screening.
Challenges and Opportunities:
- Upskilling: Pharmacists will need additional training to effectively deliver these expanded services.
- Regulatory Consistency: Variations in state regulations create barriers to a uniform rollout of expanded practice capabilities.
- Public Awareness: Increasing public understanding of the expanded role of pharmacists will be crucial in driving uptake of these services.
The ESoP initiative presents an opportunity to elevate the profession while opening new revenue streams for pharmacies.
Vapes in Pharmacy: A Contentious Issue
The role of pharmacies in dispensing nicotine vaping products (NVPs) is a topic of ongoing debate. Current regulations in Australia require a prescription for NVPs, with pharmacies playing a pivotal role in providing access as part of smoking cessation efforts.
Benefits:
- Harm Reduction: Pharmacies can help smokers transition away from traditional cigarettes by providing regulated access to vapes.
- Expert Guidance: Pharmacists can ensure that patients receive appropriate advice on the safe and effective use of NVPs.
Concerns:
- Reputation Risk: Associating pharmacies with vapes could lead to reputational challenges, particularly if vaping remains controversial.
- Regulatory Complexity: Pharmacists must navigate strict prescription and compliance requirements, adding to the operational burden.
- Youth Access: There is concern that normalising vape availability in pharmacies could inadvertently promote usage among young people.
Pharmacies must carefully balance their role in harm reduction with public health responsibilities and ethical considerations.
Navigating the Changing Landscape
Pharmacies must adapt strategically to thrive in the face of these changes. Key strategies include:
- Investing in Technology: Utilising digital tools like medication management apps and automated dispensing systems to improve efficiency and patient engagement.
- Focusing on Professional Services: Expanding into professional health services can help offset revenue losses from 60-day dispensing.
- Advocacy and Representation: Active participation in industry discussions ensures pharmacists’ voices are heard in shaping future policies and agreements.
- Patient Education: Raising awareness about the expanded roles and services offered by pharmacies can drive patient engagement and satisfaction.
While these developments bring challenges, they also open new opportunities for innovation, diversification, and growth. By embracing these changes and focusing on patient-centric care, pharmacies can solidify their position as essential healthcare providers in Australia’s evolving healthcare landscape.
About the Author
Wayne Marinoff has worked in senior commercial positions for over 30 years within the pharmaceutical industry. Currently President ANZ at MedAdvisor Solutions, Wayne is known for his expertise in pharmaceutical sales, marketing, and leadership. He has played a key role in driving growth and innovation in the Australian and New Zealand markets, with strong emphasis on simplifying the medical journey. With a background in generics, branded medicines, and pharmacy solutions, Wayne has a hands-on approach to market development and team leadership. He is committed to delivering results, growing health programs, and fostering collaboration within the evolving pharmaceutical industry.
If you have further questions, would like to speak with the author or other similar experts please get in touch.